Enrich Therapeutics develops a groundbreaking non-fluidic cell discovery platform to enhance global biomedical research!

Different from the most existing microfluidic and droplet-based technologies, our platform is a game-changing innovation. It enables a streamlined workflow of cell culturing, kinetics profiling, and guided capturing.

Enrich Therapeutics' non-fluidic cell capture technology enables clone isolation under the desired micro-environment with real-time monitoring. Our unique visual enrichment(VE) strategy eliminates the typical pain points in cell-based scientific research and makes an extensive impact in the fields of therapeutic T-cell discovery, stem cell research, tumor genetics, and personalized precision medicine.

We are committed to delivering a complete solution of discovering meaningful clones.

Massive addressable cell isolation market with Enrich proprietary technology